ADT 2003 Annual Report Download - page 17

Download and view the complete annual report

Please find page 17 of the 2003 ADT annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 132

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132

At Tyco Healthcare, we’re committed to delivering innovative,
high-quality healthcare solutions that improve patient out-
comes and the quality of life for people throughout the world.
With more than 75% of our sales from products that are ranked
first or second in their respective markets, Tyco Healthcare is
well positioned for long-term growth.
AMONG OUR 2003 HIGHLIGHTS
•• U.S. Surgical’s SYNETURE suture line is transforming the market
with such innovative products as CAPROSYN, an absorbable
monofilament suture, and DERMAX cosmetic surgery needles.
•• Tyco Healthcare’s leadership in respiratory devices and air-
way management systems was strengthened with the
introduction of HELIOS, a three-pound portable oxygen unit
that has revolutionized respiratory therapy by replacing large,
cumbersome oxygen tanks traditionally used by patients in
need of long-term oxygen therapy.
•• Kendall’s new MONOJECT MAGELLAN safety needle is an
innovative breakthrough in the fight to prevent accidental
needlestick injuries, and this important technology is being
rapidly adopted within the medical industry.
•• Tyco Healthcare’s pharmaceutical group has become the
world’s largest producer of acetaminophen and opiate-based
pain management pharmaceuticals.
•• As the industry leader for retailer brand adult incontinence
care, infant care and feminine hygiene products, Tyco Health-
care’s retail division supplies virtually every retail mass
merchandiser, food store and drug store chain in Canada and
the United States.
ORGANIC GROWTH
New product development remains a critical component of the
segment’s strategy. In 2003, Tyco Healthcare began imple-
menting a best-in-class product development process, known
as EDGE (Encouraging Development for Global Expansion), and
committed significant funding to new R&D efforts.
OPERATIONAL EXCELLENCE
Six Sigma and Lean Manufacturing initiatives, established at
Tyco Healthcare three years ago, have resulted in substantial
cost reductions and improved management of working capital.
Looking Ahead
An aging population continues to drive demand for Tyco
Healthcare products, and more than ever, clinicians and patients
are seeking high-quality, less invasive healthcare treatments.
Tyco Healthcare remains committed to growing its worldwide
infrastructure, sales support and production facilities to satisfy
this escalating market.
15
MALLINCKRODT’S OPTIBOLUS software extends our leadership as a total
solutions provider for computed tomography (CT) contrast delivery.
OPTIBOLUS software manages the injection of contrast agent drugs during
CT imaging procedures — dramatically improving CT visualization for optimal
image quality.
Kendall produces nearly 270,000 miles of gauze
products each year, including the industry-leading
KERLIX brand — enough gauze to circle the earth and
still reach the moon.
Innovating for a Better
Quality of Life
SEGMENT HIGHLIGHTS
Tyco Healthcare’s Mallinckrodt division is the first
drug manufacturer to introduce a line of generic
MORPHINE SULFATE EXTENDED-RELEASE TABLETS
that includes unit dose and punch-card packaging.
The addition of this new pain management product
addresses an important market need.
NELLCOR’S OXIMAX PULSE OXIMETER, featuring an
embedded digital chip, is a dramatic breakthrough
in pulse oximetry, the technology used to measure
blood oxygen levels in the human body. In the first
18 months since the system was introduced, more
than 28,000 units have been sold.